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Cryptococcus neoformans (Cn) is the most common cause of fungal meningitis worldwide. In
infected patients, growth of the fungus can occur within the phagolysosome of phagocytic cells,
especially in non-activated macrophages of immunocompromised subjects. Since this environment
is characteristically acidic, Cn must adapt to low pH to survive and efﬁciently cause disease. In the
present work, we designed, tested, and experimentally validated a theoretical model of the
sphingolipid biochemical pathway in Cn under acidic conditions. Simulations of metabolic ﬂuxes
and enzyme deletions or downregulation led to predictions that show good agreement with
experimental results generated post hoc and reconcile intuitively puzzling results. This study
demonstrates how biochemical modeling can yield testable predictions and aid our understanding
of fungal pathogenesis through the design and computational simulation of hypothetical
experiments.
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Introduction
Cryptococcusneoformans (Cn)isafungalpathogen thatinfects
humans via the respiratory tract. It is an environmental
microorganism particularly present in pigeon droppings or
associated with eucalyptus tree but it can be isolated from soil,
water, milk, fruits, horse intestinal ﬂora, bird nests, bats,
burns, and cockroaches. Once inhaled in the lung, dissemina-
tion of the infection through the bloodstream leads to the
development of a life-threatening meningoencephalitis, parti-
cularly in immunocompromised patients (Casadevall and
Perfect, 1998; Perfect, 2005). An important characteristic that
enables the fungus to cause disease is its ability to grow in
alkaline, neutral, and acidic environments of the human body.
Alkaline/neutral environments are found extracellularly, such
as in alveolar spaces and in the bloodstream, whereas acidic
environments are characteristically found intracellularly,
within the phagolysosome of host phagocytic cells (Feldmes-
ser et al, 2001). Indeed, Cn is a facultative intracellular
pathogen and can move in and out without killing host cells
(Alvarez and Casadevall, 2006; Ma et al, 2006). In doing so, it
constantly needs to adapt to a new environment, for instance,
bychanging the organization of different cellularcomponents,
gene expression, protein activities, or arrangements of lipids
within membranes.
It might be impossible to fully understand this adaptation
using a purely reductionistic approach because of continual
changes in the production and degradation of key cellular
components and because of the complex interplay among
these components during switches in the environment.
Instead, the use of systems biological methods might offer an
opportunity to complement reductionistic insights by explain-
ing complex, systemic behaviors, such as cellular adaptation
to environments, through the simultaneous investigation of
stimuli and responses of several enzymes and metabolites in
terms of space, time, and context. The spatial aspect is
important because it accounts for compartmentalization and
the topographic relationships among the components; the
need to consider time is evident, given the dramatic dynamic
changes in the molecular characteristics during adaptation;
and addressing the cellular and environmental context at each
time point accounts for the interdependencies between all
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2006a,b). Thus, system biology has a chance of shedding light
on the complexities that govern microbial metabolic path-
ways, and their regulation and adaptations may ultimately
allow us to predict cellular or biological phenotypes without
the need for large-scale wet experimentation. Speciﬁcally for
the case of Cn, the application of systems biological concepts
mayprovidesigniﬁcantinsights intothemechanismsoffungal
pathogenesis and into the complex interplay between the
fungus and the host immunity in chronic fungal diseases.
In all eukaryotic cells, the main intracellular pH regulator is
the plasma membrane H
þATPase (Pma1) pump, whose
activation results in proton extrusion, maintaining the
intracellular pH neutral (Serrano et al, 1986; Serrano, 1988)
even if the extracellular pH is acidic (Perona et al, 1990;
Portilloetal,1991).InSaccharomycescerevisiae(Sc)andinCn,
Pma1 is essential for cell viability (Soteropoulos et al, 2000),
suggesting that Pma1 has a key role in regulating the
intracellular pH. Many studies in Sc proposed a role for
sphingolipids in the regulation of Pma1 function in the
endoplasmic reticulum (ER) and at the plasma membrane
(Patton et al, 1992; Lee et al, 2002; Wang and Chang, 2002;
Gaigg et al, 2005, 2006; Toulmay and Schneiter, 2007).
The basic structural component of sphingolipids is a
long-chain sphingoid base backbone (e.g., sphingosine or
phytosphingosine (PHS)). The linkage of a fatty acid to the
two-amino group of this backbone through an amide bond
yields ceramide or phytoceramide. Complex sphingolipids are
formed with the addition of a polar group to ceramide (or
phytoceramide) via an ester bond at the C-1 position. The
synthesis of sphingolipid occurs in all eukaryotic cells and, in
addition to being common components of membranes, they
have been recognized to function as signaling molecules in a
variety of signaling pathways (reviewed in Futerman and
Hannun, 2004). In mammalian cells, sphingolipids such as
ceramide, ceramide-1-phosphate, and sphingosine-1-phos-
phate have key roles in the regulation of cellular proliferation,
stress responses, cell cycle, apoptosis, inﬂammation, and
immune response (reviewed in Luberto and Hannun, 1999;
Hannun and Luberto, 2000; McQuiston et al, 2006).
In Cn, sphingolipids have emerged as important molecules
requiredforgrowthandsignalinginalkaline/neutral(Liuetal,
2005; Rittershaus et al, 2006; Saito et al, 2006) and acidic
(Buede et al, 1991; Berne et al, 2005; Shea et al, 2006)
environments. Thus, we hypothesize that when Cn shifts from
a neutral/alkaline environment, such as extracellular alveolar
spaces or the bloodstream, to an acidic environment, such as
the phagolysosome of phagocytic cells, it should promote a
biochemical response associated with its sphingolipid path-
way, with a consequent metabolic adaptation to the new
environment.
In this study, we thus developed a mathematical model of
sphingolipid metabolism in the pathogenic fungus Cn and
made reliable predictions on its biochemical sphingolipid
adaptation to a shift from an alkaline to an acidic pH,
mimicking the internalization of the fungus by phagocytic
cells. The model was designed and analyzed within the
framework of Biochemical System Theory (BST), which uses
power-law representations for all enzymatic and transport
processes (Savageau, 1969a,b, 1976; Torres and Voit, 2002).
Results
The resultsof ourstudies fall into threecategories. The ﬁrst set
describes experimental studies that identiﬁed inositol phos-
phorylceramidesynthase(Ipc1),inositolphosphosphingolipid
phospholipase C (Isc1), and phytoceramides of different
lengths as important contributors to the response of Cn to
H
þATPase pump (Pma1) and ATP-mediated shifts in pH.
EspeciallytheputativerolesoftheenzymesIpc1andIsc1seem
puzzling, because these enzymes catalyze opposite directions
of the reversible reaction between phytoceramide and inositol
phosphoryl ceramide (IPC). The second set of studies used a
mathematical systems model to elucidate how the different
contributors might lead to an appropriate stress response. This
modelin turnmade predictionsregarding Pma1and theroleof
ATP, which we investigated experimentally in the third set of
studies as model validation.
Experimental studies identifying Ipc1, Isc1,
and phytoceramide as drivers of pH response
Effect of Ipc1 downregulation and Isc1 deletion on
growth of Cn in acidic environments
Inositol phosphoryl ceramide synthase 1 (Ipc1) is a fungal
enzyme localized in the Golgi apparatus in Sc (Levine et al,
2000) and Cn (M Del Poeta, unpublished data). It transfers
inositol phosphate from phosphatidylinositol (PI) to phytocer-
amide, producing IPC and 1,2-sn-diacylglycerol (DAG) (Kur-
oda et al, 1999; Heidler and Radding, 2000). Isc1 is an enzyme
localized in the ER and breaks down IPC, mannosyl-IPC
(MIPC), and mannosyl diphosphoryl ceramide (M(IP)2C)
to phytoceramide, inositol phosphate (MIP), and M(IP)2,
respectively (Dickson and Lester, 1999). We tested a
mutant in which Ipc1 is downregulated, GAL7:IPC1, grown
on glucose medium, and found that it fails to adapt with
sufﬁcient speed to an acidic environment and, as a conse-
quence, its growth is signiﬁcantly retarded (Supplementary
Figure 1A) (Luberto et al, 2001). Similarly, a mutant strain in
which Isc1 was deleted, Disc1, showed a delay in the
adaptation to a low-pH environment (Supplementary Figure
1B) (Buede et al, 1991; Berne et al, 2005; Shea et al, 2006).
Thus, two enzymes with ‘opposite’ biochemical activities
(Ipc1 uses phytoceramide as a substrate and produces IPC,
whereas Isc1 uses IPC as a substrate and produces phytocer-
amide) have the same effect on viability in changing pH
environments. This puzzling ﬁnding was quite intriguing
and warranted further investigations at the systems level
(see ‘Computational studies’).
Measurement of phytoceramide subspecies in Cn wild
type during growth at alkaline/neutral and acidic pH
Fungal cells produce variant species of phytoceramide that
differ principally in the lengths of their acyl chains and their
hydroxylation states (Vaena de Avalos et al, 2004, 2005). This
variability led to the question of whether phytoceramide
subspecies levels would change when cells are shifted from a
neutraltoanacidicenvironment.Targetedexperimentsindeed
revealed that in Cn cells exposed to a low-pH environment, the
total level of non-hydroxylated phytoceramide decreases to
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to 1588.7±6.32pmol/pmol Pi; Po0.05), whereas the total
level of hydroxylated phytoceramides increases signiﬁcantly
compared to that in neutral pH (from 1244.1±3.2 to
2147.2±3.5pmol/pmol Pi) (Table I). Analysis of the different
phytoceramide subspecies revealed that very long-chain
phytoceramides(both C26 hydroxylatedand non-hydroxylated
forms) were signiﬁcantly elevated at low compared to neutral
pH, whereas short-chain non-hydroxylated phytoceramides
(C14,C 16, and C18) were signiﬁcantly decreased at low
compared to neutral pH (Po0.05). Phytoceramide measure-
mentswerealsoperformedatalkaline pH(7.4). Nodifferences
were found in phytoceramide levels or phytoceramide
subspecies between pH 7.0 and 7.4 (data not shown). These
results suggest that Cn changes the metabolism of certain
phytoceramide subspecies when shifted from a neutral/alka-
line to an acidic environment.
Ebselen causes elevated inhibition in Isc1 mutant
As the plasma membrane proton pump H
þATPase (Pma1) is
one of the major regulators of intracellular H
þ (Serrano et al,
1986; Serrano, 1988), we wondered whether the absence of
Isc1 or downregulation of Ipc1 would affect the susceptibility
of yeast cells to Pma1 inhibitors. To address this question, we
examined the minimal inhibitory concentration (MIC) and
minimal fungicidal concentration (MFC) of ebselen, a well-
established inhibitor of fungal Pma1 (Perlin et al, 1997). We
found that loss of Isc1 or downregulation of Ipc1 signiﬁcantly
increases the susceptibility of yeast cells to ebselen (Table II),
suggesting that both Isc1 and Ipc1 may potentially regulate
Pma1 function.
Computational studies
The diagram of all reaction steps that were deemed important
in the sphingolipid pathway of Cn and on which the model is
based is presented in Figure 1. Most analyses reﬂect the late-
log phase of growth at acidic pH.
We adapted an earlier sphingolipid model for yeast
(Alvarez-Vasquez et al, 2004, 2005) to the peculiarities of
Cn. Importantly, we incorporated several organelles that
separate the physical synthesis of metabolites. Also the new
model was developed during late-log phase and it contains
several newly determined metabolite levels and enzyme
activities in wild-type (WT) Cn grown at acidic pH. In addition
to allowing for ceramides with different fatty acid
chain lengths, the new model accounts for mechanisms of
transporting protons between the cytosol and the phagolyso-
some, which are crucial for the survival of Cn. Since
Pma1 trafﬁcking (Gaigg et al, 2005) and function (Lee et al,
2002) are controlled by very long-chain phytoceramides,
the mathematical model of Cn sphingolipid pathway
proposed here pays particular attention to the dynamics of
Pma1, as well as to short-chain and very long-chain
phytoceramides and the enzymes that directly and indirectly
regulate their production.
The model analyses fall into twocategories. As it is standard
in BST, we ﬁrst diagnosed the model by thoroughly investigat-
ing its stabilityand robustnessand evaluating sensitivities and
gains, especially with respect to enzyme activities. Most of the
results of these analyses are unremarkable and are therefore
presented in Supplementary information. The gains provided
us with some insights into which metabolites are most
affected by changes in particular enzymes and transport
steps. However, they did not reveal compelling explanations
of how Cn coordinates responses to shifts in pH. By
contrast, exploration of the consequences of alterations in
Ipc1 and Isc1 suggested interesting mechanisms of handling
protons. All analyses were executed with the free software
PLAS
r (Ferreira, 2000).
The cellular compartments involved in the model are as
follows.
Cytoplasm
We include the transport of palmitate and serine, required for
the ﬁrst step of sphingolipid biosynthesis. In acidic conditions,
as they exist inside macrophages, protons move into the cell.
The inclusion of proton transport is important for the
Table I Identiﬁcation of ceramide species at 48h of growth
Ceramide species (pmol/pmol Pi)
Phyto-
C18
Phyto-
C18;1
Phyto-
C20
Phyto-
C24
Phyto-
C24:1
Phyto-
C26
Phyto-
C26:1
a-OH-phyto-
C18
a-OH-phyto-
C18:1
a-OH-phyto-
C24
a-OH-phyto-
C26
a-OH-phyto-
C26:1
pH 7 406.6 230 60 2260 640.1 170 96 3.1 1.04 570 360 310
pH 4 215.3 180 4.5* 396* 400 222.5 170.4* 4.2 3 810 710* 620
*Po0.05 (pH 4 versus 7).
Mass spectrometric analysis of different phytoceramide and alpha hydroxyl phytoceramide species during late-log phase in a Cn H99 WTstrain. Determinations are to
neutral pH or acidic pH. The mass of each species was normalized to phosphorous levels of each sample. Results are the means of three separate experiments. The
concentrations are reported as pmol/pmol Pi for phyto- (phytoceramide) and a-OH-phyto (alpha hydroxyl phytoceramide) with different length fatty acid chains.
Table II Loss of Isc1 sensitizes Cn to the Pma1 inhibitor ebselen
a
Strain pH 7 (mM) pH 4 (mM)
WT 3.12 2.48
Disc1 3.12 0.78*
Disc1
REC 3.12 3.12
GAL7:IPC1-glucose 3.12 0.39*
*Po0.05 (pH 4 versus 7).
aEbselenisfungicidaltoWT,Disc1,Disc1
REC,andGAL7:IPC1strainsatanMFCof
3.12mM at a neutral pH. The Disc1 mutant and GAL7:IPC1 strain grown on
glucose (Ipc1 downregulated) showed MFCs of 0.78 and 0.39mM, respectively.
Results are the means of three separate experiments.
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þATPase (Pma1) and cytoplasmic pH.
Proton import into the fungal cytosol is modeled as a simple
(ﬁrst order) transport process, whereas the export mechanism
depends highly on Pma1. A simple transport process implies
direct proportionality between proton inﬂux (inside the
fungus) and the external proton concentration (outside the
fungus but inside the phagolysosome). Our model considers
the fungal ATP synthesis and degradation (Supplementary
Table S7) and includes the F0F1-ATPase in the fungal
mitochondria (equation 17). Our model assumes that the
fungus is inside the phagolysosome (its physiological envir-
onmentonceinternalizedbyhostmacrophages)withnodirect
contact with the host mitochondria. For instance, we refer to a
simple transport process when the proton inﬂux depends
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(X125) utilizes energy obtained directly from ATP hydrolysis to
transport protons against the electrochemical differences
across the plasma membrane.
Endoplasmic reticulum
The ﬁrst steps of the sphingolipid pathway take place in the
ER. The condensation of serine and the acyl group transferred
from palmitoyl-CoA form 3-ketodihydrosphingosine (KDHS).
This reaction is catalyzed by serine palmitoyltransferase
(Buede et al, 1991). KDHS is rapidly converted into dihydro-
sphingosine (DHS). In the model, DHS can be converted by a
hydroxylase to PHS. At the same time, under the action of a
speciﬁc ceramide synthase (sphingoid base N-acyl transfer-
ase), DHS and a long-chain fatty acid CoA may form
dihydroceramides C18, C24, and C26. PHS may combine with
long-chainfattyacidCoAtoformphytoceramidesC18,C24,and
C26. Both dihydroceramides C18, C24, and C26 and phytocer-
amides C18, C24, and C26 may undergo hydrolytic reactions to
form DHS and PHS, respectively, which are catalyzed by
speciﬁc ceramidases (Mao and Obeid, 2000; Mao et al, 2000).
In the model, dihydroceramide C26 may be hydroxylated
directly to phytoceramide C26. Once produced, the transport of
phytoceramides C18, C24, and C26 from ER to Golgi apparatus
follows a ﬁrst-order process.
The model considers that the biosynthesis of
phytoceramide and Pma1 occurs in the ER. The Pma1 in the
ER compartment has an activity in response to pH
signals similar to the Pma1 inserted in the plasma membrane,
as previously suggested (Portillo et al, 1989). The model
predicts that Pma1 is stabilized by phytoceramide C26
produced by Isc1 (Lee et al, 2002). The model also considers
Sec61, which was found to be upregulated during murine
macrophage infection of Cn(Fanet al, 2005), asecretoryfactor
that could mediate the insertion of Pma1 into vesicles. Pma1
travels from the ER to the Golgi apparatus and ﬁnally
to the plasma membrane where it is inserted (Chang and
Slayman, 1991).
Golgi apparatus
In the Golgi apparatus, phytoceramides C18, C24, and C26 are
substratesfor Ipc1.Ipc1 transfersinositolphosphatefromPIto
phytoceramide(s), producing IPC (IPC-C18,- C 24, and -C26) and
DAG. Ipc1 is localized in the Golgi apparatus, implying that
phytoceramides are transported from the ER to the Golgi
apparatus.
IPC(s) can also be mannosylated, forming MIPC, and MIPC
can be transformed into M(IP)2C by the action of inositol
phosphoryl transferase 1. For simplicity, MIPC, M(IP)2C, and
It1 are not considered in the model. Also, we hypothesize that
IPC-C26 is transported from the Golgi apparatus to the ER and
used by the ER enzyme Isc1 to produce phytoceramide C26.
The model does not differentiate among trans-, medial-, and
cis-Golgi. The synthesis of complex sphingolipids (IPCs,
MIPCs, and M(IP)2Cs) occurs in the Golgi apparatus and their
different distribution in other membranes implies the ex-
istence of a sorting mechanism for complex sphingolipids.
Indeed, the presence of inositol-containing sphingolipids in
organelles of the secretory pathway has been suggested
(Hechtberger et al, 1994). Synthesis and transport of sphingo-
lipids in yeasts, especially complex sphingolipids, has been
poorlystudied.However,phytoceramideisindeedproducedin
the ER and transported to the Golgi apparatus, independent of
vesicular trafﬁc because IPC synthesis still continues when
vesicular transport is blocked in sec mutants (Funato and
Riezman, 2001).
Mitochondria
Mitochondria are the major producers of ATP. In yeast, the
F0F1-ATP synthase is the protein that is responsible for the
aerobic synthesis of ATP, and it is localized in the inner
mitochondrial membrane (Fronzes et al, 2003). The F1F0-ATP
synthase is important for the regulation of intracellular pH,
implicating mitochondria as a major regulator of cytoplasmic
pH (Matsuyama and Reed, 2000). Although in rat liver the
cytosolic-mitochondrialdeltapHcanbebetween0.06and0.31
pH units when the cytosol is acidiﬁed with permeant weak
acids (Durand et al, 1999), there is no much literature on in
vivo mitochondria-cytosol pH recordings.
In Cn, as in other eukaryotes, ATP is derived from
mitochondria respiration. During respiration, the electron
transfer chain with terminal cytochrome c oxidase (COX)
pathway generates a proton gradient, which, among other
functions, powers the synthesis of ATP through F1F0-ATP
synthase. In addition to this pathway, Cn (and other fungi,
Figure 1 Model diagram of sphingolipid metabolism in Cn. Metabolites in boxes represent dependent variables that are deﬁned through differential equations and are
numberedfromX1toX19.Independentvariables arenumberedfromX100toX136.Solidarrowsshow ﬂowofmaterial.Plus signsassociated withdotted arrows represent
activation. The acylation state is coded as (1) C26-CoA, (2) C18-CoA, and (3) C24-CoA; these are substrates for the DH-Cer synthase reaction or for the enzyme P-Cer
synthase (see main text and Supplementary information for details). Dependent variables: Pal-CoA (X1), palmitoyl-CoA; serine (X2); KDHS (X3), 3-
ketodihydrosphingosine; DHS (X4), dihydrosphingosine; dihydro-C24 (X5), dihydroceramide C24; dihydro-C26 (X6), dihydroceramide C26; dihydro-C18 (X7),
dihydroceramide C18; PHS (X8), phytosphingosine; phyto-C26 (X9), phytoceramide C26; phyto-C24 (X10), phytoceramide C24; phyto-C18 (X11), phytoceramide C18; Pma1
(X12), newly synthesized Pma1; IPC-C26 (X13), inositol phosphorylceramide C26; IPC-C24 (X14), inositol phosphorylceramide C24; IPC-C18 (X15), inositol
phosphorylceramide C18; intracellular protons (X16); ATP (X17), adenosine-50-triphosphate; palmitate (X18); DAG (X19), sn-1,2-diacylglycerol. Independent variables:
palmitate ext (X100), palmitate external; serine ext (X101), serine external; palmitate transport (X102); serine transport (X103); Ac-CoA (X104), acetyl CoA; C26-CoA (X105),
very long-chain fatty acid (C26-CoA); C18-CoA (X106), fatty acid (C18-CoA); C24-CoA (X107), fatty acid (C24-CoA); serine palmitoyltransferase (X108); ADP, adenosine
biphosphate (X109); dihydro-CDase (X110), dihydroceramide ceramidase; KDHS reductase (X111), 3-ketodihydrosphingosine reductase; DH-Cer synthase (X112),
dihydroceramide synthase; phyto-CDase (X113), phytoceramidase; hydroxylase (X114); hydroxylase (X115); P-Cer synthase (X116), phytoceramide synthase; Pma1p
(X117), newly synthesized Pma1 in the ER; Sec61 (X118), Sec61 as probable ER insertion protein; Isc1 (X119), inositol phosphosphingolipid phospholipase C; PI (X120),
phosphatidylinositol; Ipc1 (X121), inositol phosphorylceramide synthase; alternative respiration (X122); NADHm (X123), nicotinamide adenine dinucleotide; oxygen (X124);
Pma1-H
þATPase (X125), synthesized plasma membrane H
þ-ATPase; H
þ (X126), protons external; ER–Golgi transport (X127); H
þ transport (X128), proton transport;
SHMT (X129) serine hydroxymethyl transferase; Golgi membrane (X130); Pal-CoA synthase (X131), palmitoyl-CoA synthase; ATP total (X132); AMP (X133), adenosine
monophosphate; Golgi–ER transport (X134); F0F1-ATPase (X135), F0F1-ATP synthase; H
þ m (X136), mitochondrial protons.
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cyanide-resistant electron transport chain in its mitochondria.
Thispathway iscomposedofahomodimericproteinidentiﬁed
as an alternative oxidase 1 (Aox1) (Akhter et al, 2003). As
Aox1 is important for Cn to survive in acidic conditions, we
included it in the model.
In Sc, Isc1 has been found in the mitochondria during the
late-logphase(VaenadeAvalosetal,2004).Thus,thisenzyme
can form phytoceramide in the mitochondria from IPC
(Kitagaki et al, 2007). Interestingly, Sc Disc1 mutant showed
reduced levels of mitochondrial COX subunits Cox3 and Cox4
(VaenadeAvalosetal,2005),suggestingthatIsc1playarolein
the respiration by mitochondria.
Analytical model results
The model analyses fall into two categories. As itis standard in
BST,weﬁrstdiagnosedthemodelbyanalyzingitsstabilityand
evaluating its robustness through computation of sensitivities
and (logarithmic) gains, especially with respect to enzyme
activities. Most of the results of these analyses are not
particularly interesting and were therefore moved to Supple-
mentary information. The second type of analysis targets the
dynamics of the system and is accomplished through simula-
tion studies.
Eigenvalue analysis conﬁrmed the stability of the steady
state of the model. Furthermore, the system was quite robust,
as measured by sensitivity and gain proﬁles with low
magnitudes. A (logarithmic) gain quantiﬁes the effect of a
1% change in some enzyme activity on some steady-state
output quantity, such as a metabolite concentration or
a ﬂux. In the particular case of our model, no gains pointed
to obvious problems or interesting control points. As in the
earlier model for sphingolipid metabolism in yeast (Alvarez-
Vasquez et al, 2004, 2005), the precursors serine, palmitate,
and fatty acid-CoA, as well as the initial transport and
kinetic steps, by and large have the highest gains, which is
intuitively reasonable because they determine the entire
input to the system, while most other reactions merely
redistribute material within the system. Outside the ‘input
mechanisms,’ non-obvious positive, relatively high gains
were found for dihydroceramide synthase (X112), dihydrocer-
amide hydroxylase (X115), and Ipc1 (X121); increases in their
activities result in changes in phytoceramide levels. High
negative gains were seen for dihydroceramide ceramidase
(X110), phytoceramidase (X113), hydroxylase (X114); increases
in their activities result in decreases in phytoceramide
levels. Of interest is that none of the gains are extraordinarily
high and that gains with respect to Pma1 are largely
unremarkable. A similar analysis of ﬂux gains did not add
further insight. The log gains are closely related to kinetic
parametersensitivities,whichweretherefore,notsurprisingly,
not remarkable either.
The gains provided us with modest insights into which
metabolites are most affected by changes in particular
enzymes and transport steps. However, they did not reveal
compelling explanations of how Cn coordinates responses to
shifts in pH. Therefore, we used simulations to explore
mechanisms of proton handling and the role of alterations in
Ipc1andIsc1inthesemechanisms.Allanalyseswereexecuted
with the free software PLAS
r (Ferreira, 2000). The Isc1
simulation was made with a 95% decrease in activity and Ipc1
perturbations were implemented with 85% decreases. These
alterations were initiated in the simulations at time 1min. We
selected for our discussion of results the simulations most
relevant for the analysis of regulation of Pma1 by phytocer-
amide with respect to internal proton concentrations.
Effect of decreased Isc1 (X119)
The ‘static’ gain analysis was not able to rationalize the means
by which Cn responds to shifts in pH. Because our biological
experiments pointed to Isc1 and Ipc1 as potential contributors
to the acidity response, we simulated changes in their
activities, which in reality would probably be achieved
through alterations in gene expression, following sensing
and signal transduction.
Figure 2 shows the responses to a 95% decrease in Isc1
activity.Thetransientsinthisﬁgurearenotasimportantasthe
ﬁnal state of the system, because we are modeling an ‘inborn’
mutation, as opposed to something like a sudden change in
substrate. It is evident that phytoceramide C26 (X9) and ATP
(X17) levels are dramatically and permanently decreased in
this situation. Other key sphingolipids (X1–X7, X4–X15, and
X18) are not signiﬁcantly affected by this perturbation. By
contrast,lossofIsc1activityseverelydiminishesPma1activity
(X12), and the cytoplasmic pH decreases from 6.5 to 3.6 and
does not return to its nominal state, in which Isc1 shows
normal activity.
Effect of decreased Ipc1 (X121) activity
Decreases in the activity of Ipc1 (X121) similarly affect Pma1
function (see Figure 3 for the consequences of a 85%
decrease). In this simulation of a low-pH environment, IPC-
C26 (X13), phytoceramide C18 (X11), and Pma1 (X12) decrease,
Figure 2 Simulation result of a 95% decrease in Isc1 (X119) activity. Phyto-C26
(X9), Pma1 (X12), and ATP (X17) decrease. The remaining metabolites stay close
to their initial values, except for IPC-C26 (X13), which increases. The intracellular
pH decreases from 6.5 to 3.6.
Modeling fungal pathogenesis
J Garcia et al
6 Molecular Systems Biology 2008 & 2008 EMBO and Nature Publishing Groupwhereas phytoceramide C26 (X9) increases. The intracellular
pH decreases from 6.5 to 5.4 and does not return to its normal
state.
Validation of the model
The biochemical conditions considered in the model support
thesimpliﬁedscheme(Figure1)ofsphingolipidmetabolismin
CninacidandneutralpHenvironmentsandallowustopredict
how changes are transduced to Pma1 activity. As the model
predictions are very speciﬁc, it is not difﬁcult in this particular
case to test some of them in the laboratory. In other words, the
model effectively narrowed the range of most promising
experimental targets from potentially very many to just a few.
Table III shows comparisons between model deductions and
observations.
According to mass spectrometric measurements, Cn WT
produces more phytoceramide C26 in acidic compared to
neutral conditions (Table I), but the same amounts of DAG
(data not shown). Our early experiments (see ‘Experimental
studies identifying Ipc1, Isc1, and phytoceramide as drivers of
pH response’) had suggested that both Ipc1 and Isc1 regulate
Pma1 function. Moreover, it seems that the level of very long-
chain phytoceramides is highly regulated by Isc1 but not by
Ipc1 (Table IV). These experimental ﬁndings were tested
against model predictions. For technical reasons, these tests
were most reliably executed by comparing model results with
experimental data for ATP and lipid measurements.
As ATP is required for Pma1 activity, we wondered whether
deletion of Isc1 or downregulation of Ipc1 would affect the
intracellular level of ATP. We found that the ATP level is
dramatically reduced when Isc1 is deleted, compared to WT
strain, but only in acidic and not neutral pH at 12, 24, and 48h
of growth (Po0.05) (Figure 4). Interestingly, downregulation
of Ipc1 does not affect ATP levels at neutral (data not shown)
or acidic conditions (Table III). The model predicts a 65%
decrease in the ATP level in the Isc1 mutant, and the
experimental data show an 80% decrease. At the same time,
the model predicts no change in the ATP level upon Ipc1
downregulation, and the experimental results show no
changes in ATP when Ipc1 activity is downregulated (Table
III and Figure 4).
Next, we performed lipid measurements in conditions
where Ipc1 was downregulated or Isc1 deleted. Loss of Isc1
leadstoaspeciﬁcdepletionofphytoceramideC26,especiallyat
pH 4, whereas no changes are observed with phytoceramide
C18 (Table IV) or other subspecies (data not shown).
Interestingly, loss of Isc1 leads to an increase of C16:1/18:1-
DAG in neutral but not acidic pH (data not shown). Down-
regulation of Ipc1 increases phytoceramide C26 compared to
theWTstrainatacidicpHbutonlyat48hofgrowth(TableIV).
At neutral pH, phytoceramide C26 does not change when Ipc1
isdownregulatedcomparedwithWT(TableIV).ThetotalDAG
level decreases when Ipc1 is downregulated (Heung et al,
2004, 2005), especially in the form of the Di-C16 DAG
subspecies (data not shown). These results suggest that Isc1
speciﬁcally produces phytoceramide C26, which implies that it
prefers IPC-C26 and/or C26 MIPC and/or C26-MIP2C compared
to other complex sphingolipid substrates. By contrast, Ipc1
seems to use mainly phytoceramide C18 as a substrate and it
appears that a rearrangement of phytoceramide species will
occur at low pH (Table IV).
Finally, we measured the activity of Pma1 in Cn WT and
mutant strains grown at pH 7.0 or 4.0. Pma1 activity was
measured in extractedcell membranes byusing an established
Figure 3 Simulation result of an 85% decrease in Ipc1 (X121) activity. Phyto-
C18 (X11), IPC-C26 (X13), and Pma1 (X12) decrease, whereas phyto-C26 (X9) and
phyto-C24 (X10) increase. The remaining metabolites stay close to their initial
values. The intracellular pH decreases from 6.5 to 5.4.
Table III Comparison between model predictions and experimental data for acidic pH at 48h of growth
Metabolite WT Experimental data (pmol/pmol Pi) Model predictions (pmol/pmol Pi)
GAL7:IPC1 Disc1 GAL7:IPC1 Disc1
Phytoceramide C26 (X9) 222.5 523.3 10 465.08 9.37
Phytoceramide C18 (X11) 215.3 114.6 235 179.65 173.80
ATP (X17)
a 82.48 80.36 16.92* 82.48 29.17
apmol/mg protein.
*Po0.05, Disc1 versus WT.
PhytoceramideC26levelisincreasedwhenIpc1isdownregulatedintheGAL7:IPC1-glucosestraincomparedtothecontrolWTstrainsatpH4.Valuesareconcentrations
in pmol phytoceramide C18 or C26/pmol phosphate (Pi). Results shown are the means of three independent experiments. ATP is signiﬁcantly lower in the Disc1 mutant
compared to the control strain (WT) at pH 4.
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2000). We then calculated Vmax and KM of Pma1 using the
Lineweaver–Burk method, which linearizes the Michaelis–
Menten equation by taking the reciprocal of both sides of the
equation 1/v0¼1/Vmaxþ(KM/Vmax)(1/[S])). We found that
the KM of Pma1 increased by B9- and B7-fold in Disc1 and
GAL7:IPC1mutantsgrownatpH4.0,respectively,comparedto
WT or Disc1-Rec, whereas no signiﬁcant changes were
observed in Vmax (Table V). A slightly increased value of KM
inthemutantswasalsopresentwhenstrainsweregrownatpH
7.0, but the difference was not signiﬁcant (data not shown).
These results suggest that the afﬁnity of Pma1 for ATP is
dramatically reduced when Isc1 is deleted or Ipc1 down-
regulated.
Perhaps the oligomerization of Pma1 is impaired in the
mutants compared to control strains and this effect is
particularly present at pH 4.0. These results strongly validate
our model in which very long-chain phytoceramides, such as
the product of Isc1 phytoceramide C26, are predicted to
regulate Pma1 oligomerization. They also suggest, however,
thatverylong-chainphytoceramidesarenottheonlyregulators
of Pma1 because Pma1 activity is also impaired in the
GAL7:IPC1 strain in which phytoceramide C26 level is normal.
Discussion
This article presents a mathematical model that provides
rationale for some expected and some counterintuitive
Table IV Experimental measurements of phytoceramides C18 and C26 in Cn WT, GAL7:IPC1,a n dDisc1 mutant strains during in vitro growth at neutral and acidic pH
Parameter 12h 24h 48h
WT GAL7:IPC1 Disc1 WT GAL7:IPC1 Disc1 WT GAL7:IPC1 Disc1
pH 7
Phyto-C18 482 1333 430 517 1090 530 406.6 900 980
Phyto-C26 225 244 75* 280 263 40* 170 245 150
PH 4
Phyto-C18 207 45.2 180 220 96.6 240 215.3 114.6 235
Phyto-C26 340 320 20* 443 470 10* 222.5 523.3 10*
Ipc1 is downregulated in the GAL7:IPC1-glucose strain and Isc1 is deleted in the Disc1 strain. Downregulation of Ipc1 shows an increase of phytoceramide C18 (phyto-
C18) at neutral pH. In contrast, phytoceramide C26 (phyto-C26) is slightly increased in GAL7:IPC1 compared to WTstrain at acidic pH but only at 48h of growth.
The level of phytoceramide C26 is signiﬁcantly reduced in the Disc1 mutant compared to the WTstrain (*Po0.05). Measurements of phytoceramides C18 and C26 were
also performed in the Disc1-reconstituted strain, and no signiﬁcant differences were found in comparison with the WT strain (data not shown). Values are
concentrations in pmol phytoceramide C18 or C26/pmol phosphate (Pi). Results shown are the means of three independent experiments.
Figure 4 Measurement of intracellular ATP in Disc1 mutant and control strains
during growth at neutral and acidic pH. (A) Production of ATP is not impaired in
the Disc1 strain when exposed to a neutral pH environment. (B) Production of
ATP is signiﬁcantly impaired in the Disc1 strain when exposed to a low-pH
environment. Values are reported as pmol/mg protein. Results are means±s.d.
of three separate experiments. *Po0.05, Disc1 versus WT.
Table V Experimental measurement of KM and Vmax of Pma1 in Cn WT, Disc1,
Disc1-reconstituted (Disc1-Rec), and GAL7:IPC1 strains in cell membranes
extracted from cells grown at pH 4.0
pH 4.0
Vmax (nmol Pi/mg/min) KM (mM)
WT 3.58 0.65
Disc1 4.58 5.96
Disc1-Rec 3.18 0.84
GAL7:IPC1 4.64 6.21
KM of Pma1 in Disc1 and GAL7:IPC1 strains increased by B9- and 7-fold
respectively compared to the KM of Pma1 in WT or Disc1-Rec strains. No
signiﬁcant changes were observed in Vmax. Also, no signiﬁcant changes in Vmax
and KM were observed when strains were grown at pH 7.0 (data not shown).
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acidic environments. The model focuses in particular on the
metabolism of phytoceramides and predicts speciﬁcally that
certain phytoceramide subspecies (C26) play a key role in the
regulation of adaptation of Cn to low pH. To our knowledge,
this is the ﬁrst mathematical model proposed for Cn
pathogenesis. While no model can be proved to be ‘correct,’
our results indicate that the model is quite robust and accurate
because all model predictions tested so far were validated
successfully.
We experimentally conﬁrmed that the concentration of
phytoceramides is affected when cells are shifted from a
neutral to an acidic environment. In acidic pH, the phytocer-
amide C26 subspecies increase compared to other subspecies
and the production of phytoceramide C26 at low pH appears to
be dependenton Isc1 activity. In conditions inwhich mostIsc1
activity is lost, phytoceramide C26 cannot be formed and the
intracellular ATP concentration is low. As a consequence,
Pma1 activity is impaired by decreasing the afﬁnity to the
substrate. Under these conditions, cells exposed to an acidic
environmentdonotdiebut,interestingly,needadditionaltime
to adapt before they can grow.
The transformation of complex sphingolipids into phytocer-
amide by the action of Isc1 is a process that mainly occurs in
the ER but can also occur in other organelles. For instance, it
was suggested that, in addition to ER localization, Isc1 in Sc
may also be localized in the mitochondria (Vaena de Avalos
et al, 2004). This localization hypothesis is supported by
mammalian studies in which sphingomyelinase, the counter-
part of Isc1 in mammalian cells, is localized in the mitochon-
driainadditiontotheER(Birbesetal,2001,2005).Inaddition,
recent studies showed that Isc1 produces phytoceramides in
mitochondria, in particular a-hydroxylated phytoceramide C26
but also other species such as non-hydroxylated phytocer-
amides C18, C24, and C26 (Kitagaki et al, 2007). Production of
these sphingolipids by Isc1 implies that IPCs formed in the
Golgi apparatus are transported to the ER. Currently, it is not
known whether complex sphingolipid transport occurs, but
since the transport of phospholipids between mitochondria
and the ER can occur through membrane association
(Achleitner et al, 1999), it is possible that IPCs could be
transported as well.
In the mitochondrial membrane, the degradation of IPCs
into phytoceramides may have important consequences for
the membrane potential and the generation of ATP. In our
system, the reduction of ATP level in the absence of Isc1
suggests a potential role of Isc1 in mitochondria in the
regulation of ATP synthesis.
In conditions in which Ipc1 is downregulated, yeast cells
also need additional time to adapt but this initial adaptation
appears to be independent of phytoceramide C26. Indeed, the
level of phytoceramide C26 does not decrease upon down-
regulation of Ipc1 but, instead, increases at low pH. Thus, it is
proposed that Ipc1 regulates growth at low pH and Pma1
activity through the formation of IPC and/or DAG. IPC is a
complex sphingolipid that is important for the integrity of the
plasma membrane, whereas DAG produced by Ipc1 is
important for the activation of Pkc1 and the consequent cell
wall integrity (Heung et al, 2004, 2005). Cell wall integrity,
regulated by the Ipc1–DAG–Pkc1 pathway, is required for the
proper function of the laccase enzyme in Cn (Heung
et al, 2005) and it may also be important for the proper
localization and/or oligomerization of Pma1 in the plasma
membrane.
On the other hand, a relationship between Pma1 biogenesis
and lipid synthesis is indicated by a number of observations.
Lipids containing C26 fatty acids, either phytoceramide or
glycerophospholipid bound, are important for stable biogen-
esis of Pma1 (Toulmay and Schneiter, 2006, 2007). Phytocer-
amide synthesis is also required for oligomerization and raft
association of Pma1 in the ER (Lee et al, 2002; Wang and
Chang, 2002), and oligomerization of Pma1 could be
important for stabilization of the protein once it has reached
the cell surface (Wang and Chang, 2002). Other studies also
suggestthat thesynthesis ofcomplexsphingolipids iscritically
important for Pma1 biogenesis (Gaigg et al, 2005). Indeed, in
Sc, a decrease in proton extrusion by Pma1 is observed in the
absence of complex sphingolipids, suggesting that IPC, MIPC,
and M(IP)2C may regulate Pma1 function (Achleitner et al,
1999). The fact that Isc1 and Ipc1 activities are required for
Pma1 stability is supported by the observation that, in
conditions in which Isc1 is deleted or Ipc1 downregulated,
the mutant is hypersensitive to ebselen and the KM of Pma1
signiﬁcantly increased. Our results are in concordance with
yeast studies by Patton et al (1992), in which sphingolipid
deﬁciency causes a deﬁciency in net proton extrusion under
acidic pH.Morerecentstudiesshowthat ifPma1isnotdirectly
complexed with very long-chain phytoceramide, its function
may be lost and the cells are unable to grow at low pH (Gaigg
et al, 2006).
Based on our simulations, the model suggests that Pma1
activity decreases when Isc1 is deleted or Ipc1 is down-
regulated, and our experimental ﬁndings demonstrated this
model prediction. Speciﬁcally, the model suggests that Isc1
and Ipc1 regulate Pma1 through different mechanisms: Isc1
through phytoceramide C26 and Ipc1 through IPC and/or DAG.
Under acidic conditions, the cells require additional produc-
tion of phytoceramide C26. This is readily achievable by
metabolizing IPC-C26 into phytoceramide C26 by the action of
Isc1. Under conditions in which Isc1 is deleted, the cells need
more time to adapt to the acidic environment and to grow
successfully. Eventually they do, perhaps through the over-
production of speciﬁc subspecies of DAG, which was observed
at 24 and 48h when Isc1 is deleted. This overproduction of
DAG and the consequent stabilization of cell wall integrity by
Pkc1 may eventually compensate for the lack of phytocer-
amide C26 and the dysfunction of Pma1.
Under conditions in which Ipc1 is downregulated, the cells
also need more time to adapt to the acidic environment before
they can restore growth. In these cases, IPC and DAG levels
decrease and phytoceramide level increases (Heung et al,
2005). Interestingly, phytoceramide C18 increases at neutral
pH,whereasphytoceramideC26increasesat48hofincubation
at low pH (Table IV). This increase could reﬂect a compensa-
tory mechanism triggered by the Ipc1 mutant strain to restore
growth under low pH. Indeed, phytoceramide C26 increases
only at low but not neutral pH. Perhaps, Isc1, which according
to our data is the key regulator of phytoceramide C26 level,
compensates by increasing its activity in conditions where
Ipc1-downregulated cells suffer from the lack of IPC and/or
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downregulation at mid- to late-log phase and under acidic
externalconditions(datanotshown).Indeed,accumulation of
PHS was also observed experimentally when Ipc1 was
downregulated (data not shown), suggesting that other
mechanisms for the Ipc1–Pma1 regulation may exist in
addition to IPC and/or DAG.
The analysis of which genes and enzymes associated with
sphingolipidandotherpathwaysaremostimportantforfungal
cell homeostasis under certain growth conditions may have
important medical implications. For instance, one could
evaluate the level of expression of a speciﬁc gene or enzyme
in fungal cells isolated from patients and establish to what
degree the in vivo expressionwould differ in different patients.
During infection, Cn cells may reside extracellularly and
intracellularly, and the percentage of Cn cells in each
compartment is most likely to vary for a number of reasons
(e.g., expression of speciﬁc fungal virulence factors, such as
capsule, melanin, glucosylceramide, antiphagocytic protein 1
(App1), phospholipase B1 (Plb1), urease, availability of host
cells for intracellular growth, and the status of the host
immune response). In cases of host immunodeﬁciency, Cn
cells may prefer to reside in one compartment (e.g.,
intracellular) instead of the other (extracellular), and gene
expression and/or protein activities in intracellular Cn may be
completely different compared to extracellular Cn (Fan et al,
2005). Thus, if information related to a speciﬁc gene
expression or protein activity could be evaluated by a
mathematical model in cells recovered from a patient, then
we could predict the overall ﬁtness of the fungus during a
particular time of infection. For instance, overexpression of
Isc1oranelevatedlevelofphytoceramideC26wouldpredictan
intracellular localization of Cn, whereas overexpression of
glucosylceramidesynthaseanddownregulationofIpc1and/or
Isc1 would predict an extracellular localization. Such an
analysis might have important implications for the outcome of
the infection because we know that the different localization
(intracellular versus extracellular) of fungal cells may affect
the pathogenesis of Cn infection (Rittershaus et al, 2006; Shea
et al, 2006) and its susceptibility to antifungal treatment. For
instance, chloroquine increases the efﬁcacy of ﬂuconazole by
alkalinizing the intracellular compartment and favoring the
extrusion of Cn cells into the extracellular space (Mazzolla
et al, 1997; Khan et al, 2004;Alvarez and Casadevall, 2006; Ma
et al, 2006). Thus, mathematical models accounting for Cn
gene expression proﬁles and enzymatic activities at a speciﬁc
time of the infection may help to deﬁne the context (host
immunity) and the space (extracellular or intracellular) in
which the infection occurs in a speciﬁc patient. It is through a
combination of targeted, reductionistic molecular biology and
system-wide computational biology that this goal may be
achieved.
Materials and methods
Biochemical systems theory
BST has been reviewed numerous times in the recent literature (Voit,
2000; Torres and Voit, 2002), and we will discuss only its most salient
features. The starting point is the description of temporal changes in
each of the dependent variables Xi in a biochemical system with the
general system equation
dXi
dt
¼ Vþ
i ðX1;X2;X3;...;XnþmÞ
  V 
i ðX1;X2;X3;...;XnþmÞ
ð1Þ
Here, Vi
þ and Vi
  are positive valued functions that may involve some
or all of the system variables X1, X2,y,Xnþm. The ﬁrst n variables
typically change over time, whereas the remaining m are considered
constant during each mathematical experiment, but may change from
one experiment to the next. The key feature of BST is the
representation of the functions Vi
þ and Vi
  as products of power-law
functions (Savageau, 1969a,b). In the so-called S-system form, which
we will use here, the dynamics of each dynamic variable is thus
formulated as
dXi
dt
¼ ai
Y nþm
j¼1
X
gij
j   bi
Y nþm
j¼1
X
hij
j ð2Þ
Theparametersaiandbiarenon-negativerateconstants,andgijandhij
are real-valued kinetic orders. The parameters ai and gij are associated
with the aggregate rate law Vi
þ for synthesis or augmentation of Xi,
whereas bi and hij are associated with the aggregate rate law Vi
  for
degradation or elimination of Xi.
Details of model design, estimation of parameter values, and
conversions between this and other model types are presented in
Supplementary information. Simulations, stability and sensitivity
analysis, as well as the assessment of gains were executed with the
free software PLAS
r (Ferreira, 2000). Results that are not of prime
interest here are presented in Supplementary information. Sufﬁce it to
say that the model has a stable steady state, that it is overall very
robust, and that no obvious reasons to worry about its properties were
detected in extensive diagnostic studies.
Strains and growth conditions
Cn var. grubii serotype A strain H99 (WT), Cn GAL7:IPC1 (Luberto
et al, 2001) strain, Disc1 mutant, and the Disc1þISC1 (Disc1
REC)
strains(Sheaetal,2006)wereusedinthisstudy.Strainswereroutinely
grown in yeast extract/peptone/dextrose (YPD) (Difco) medium
buffered to pH 7.0 or 4.0 with 25mM HEPES. Yeast nitrogen base
(YNB)was composedof 6.7g/lyeastnitrogenbase (Difco)with amino
acids and 5g/l glucose. To downregulate Ipc1, the GAL7:IPC1 strain
was grown on glucose medium as previously described (Luberto et al,
2001; Mare et al, 2005).
Extraction and analysis of yeast sphingolipids
StrainsweregrowninYPDatpH7.0for24h,washedtwicewithsterile
distilled water, and inoculated into fresh YPD pH 7.0 or 4.0 media. At
appropriate time points (0, 6, 12, 24, and 48h), cells were collected by
centrifugation at 3000r.p.m. for 10min, washed twice with sterile
distilled water, and the pellets were stored at  801C. Neutral lipids
were extracted by the method of Bligh and Dyer (1959). An aliquot of
the extraction (300ml) wasusedfor phosphorous determination (Perry
et al, 2000). Internal standards were added to the remaining aliquots,
and sphingolipids were extracted in a one-phase neutral organic
solvent (propan-2-ol/water/ethyl acetate, 30:10:60, v/v). Samples
were then analyzed by a Surveyor/TSQ 7000 liquid chromatography–
MS system. Lipids were qualitatively deﬁned by parent-ion scanning
for known fragments characteristic for a speciﬁc sphingolipid class,
including sphingoid bases, ceramides, and phytoceramides. For all
experiments,sourceionopticswasadjustedtoaccomplishdesolvation
of ions while minimizing fragmentation of ions in the inlet region of
the mass spectrometer (Pettus et al, 2004). Samples were quantita-
tively analyzed on the basis of calibration curves generated with
synthetic standards. The mass of each species was normalized to
phosphorous levels of each sample.
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Experiments to determine MICs and MFCs were performed by the
broth microdilution method according to the recommendations of the
National Committee for Clinical Laboratory Standards (NCCLS and
Stardards, 1997). Cn strains were grown in YPD (pH 7.0) for 24h at
301C. Cells were washed twice with sterile deionized water, and the
density was adjusted to a ﬁnal concentration of 2.5 10
3cells/ml in
YNB with 25mM HEPES at a pH of 7.0 or 4.0. Ebselen was obtained
from Sigma. The MIC was deﬁned as the lowest drug concentration in
which a visual turbidity of p80% inhibition was observed compared
to that produced by the growth control. One hundred microliter
aliquots from wells with growth inhibition were plated onto YPD agar
plates. The lowest concentration that yielded three or fewer colonies
was recorded as the MFC.
Measurement of ATP level
Intracellular ATP concentrations were determined by using a
bioluminescentATPassaykit(Sigma),whichmeasurestheconversion
ofluciferintolightbyﬁreﬂy luciferaseinthepresenceofATP.Thelight
emitted is proportional to the ATP present and was measured at
490nm using a luminometer (Berthold Australia Pty Ltd, Bundoora,
Australia).CnWT,Disc1,Disc1
REC,orGAL7:IPC1strainsweregrownin
40ml of YNB containing 2% glucose with 25mM HEPES (pH 7.0 or
4.0) for 12, 24, or 48h. Cells were washed twice with sterile deionized
water. A pellet containing 5 10
8 cryptococcal cells was ﬂash-frozen
and stored at  801C. Pellets were resuspended in 800mlo f5 0 m M
HEPES (pH 7.75) and 200ml DMSO. Acid-washed glass beads were
added and cells were homogenized ﬁve times for 45s each using the
Bead-Beader-8, with samples being kept on ice for at least 1min
between homogenization cycles. After centrifugation at 2500g for
10min at 41C, the supernatant was collected to determine ATP
concentrations according to the manufacturer’s instructions. Protein
concentration of an aliquot of the supernatant was measured by the
Bradford method and was used to normalize ATP determination to
control for the extraction process.
Pma1 activity
Plasma membranes were isolated from Cn WT, Disc1, Disc1-Rec, and
GAL7:IPC1 strains grown in 250ml YNB containing 2% dextrose with
25mMHEPES(pH4or7)for24h.Themembranesforeachstrainwere
isolated by the procedure described by Wang et al (1996). Speciﬁcally,
the cells were resuspended in 25ml homogenization buffer consisting
of 100mM Tris–HCl, pH 7.5, 5mM EDTA, 5mg/ml bovine serum
albumin, and 1mM phenylmethylsulfonyl ﬂuoride, which was added
just before use. Thecells werepassedthrough a French pressure cell at
20000p.s.i. at 41C. The lysate was adjusted to pH 7 with 1M HCl and
centrifuged at 10000g for 10min. The resulting supernatant was
centrifuged at 100000g for 60min and the pellet was resuspended in
3ml extraction buffer consisting of 10mM HEPES–KOH, pH 7.0,
100mM KCl, 0.2mM EDTA, 1mM dithiothreitol, and 0.45% (w/v)
glycerol by sonication for 3 15s (15% amplitude). Deoxycholate
(10% w/v stock) was added to the suspension on ice to a ﬁnal
concentration of 0.5% w/v. This suspension was then centrifuged at
150000g for 1h. The pellet was washed by resuspension (via
sonication) in extraction buffer (3ml) and centrifuged at 150000g
for 1h. The ﬁnal pellet was resuspended in 1.5ml extraction buffer.
Protein determination was carried out using the Bradford method with
bovine serum albumin as the standard. ATPase assays were conducted
in 96-well microtiter plates similar to the method described by Wang
etal(1996).Brieﬂy,a125mlassaymixturecontained10mMMES–Tris,
pH 6.5, 0–14mM MgSO4,2 5m MN H 4Cl, 0–14mM ATP, and 0.6–1mg
membrane protein. Samples were incubated at 301C for 15min and
inorganic phosphate released from ATP was determined by the
addition of 125ml of phosphate developing reagent, consisting of
0.6M H2SO4,9 %L-ascorbic acid, and 0.9% ammonium molybdate.
The absorbance at 820nm was determined after 10min incubation at
room temperature. The amount of phosphate liberated was estimated
by using a linear standard curve in the range 0–100mM NaH2PO4. All
KM and Vmax values were obtained by determining ATP hydrolysis as a
function of substrate concentration (0–14mM for both ATP and
MgSO4) and the data were ﬁt to the Michaelis–Menten equation.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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